Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

During the Trading Day
1.62 +0.01 / +0.62%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.62 0.00 / 0.00%
 
Volume: 7.5K

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Navidea Biopharmaceuticals Inc have a median target of 5.58, with a high estimate of 9.00 and a low estimate of 2.15. The median estimate represents a +244.14% increase from the last price of 1.62.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Navidea Biopharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.04
Sales
$2.0M
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 20.00%
 
 
 
 
 
 
Growthannually 16.67%
 
 
 
 
 
 

Sales

Growthquarterly -5.14%
 
 
 
 
 
 
Growthannually 70.52%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account